ClinVar Miner

Submissions for variant NM_018668.4(VPS33B):c.403+2T>A (rs769333468)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Illumina Clinical Services Laboratory,Illumina RCV000343206 SCV000394460 pathogenic Arthrogryposis, renal dysfunction, and cholestasis 1 2017-04-27 criteria provided, single submitter clinical testing The VPS33B c.403+2T>A variant occurs in a canonical splice site (donor) and is therefore predicted to disrupt or distort the normal gene product. The variant has been reported in three studies in which it is found in a total of 17 patients with arthrogryposis, renal dysfunction, and cholestasis (ARC) syndrome, including in four in a homozygous state, in 11 in a compound heterozygous state, and in two in a heterozygous state (Cullinane et al. 2009; Jang et al. 2009; Seo et al. 2014; Wang et al. 2014). The variant was also reported in a heterozygous state in four unaffected parents. The c.403+2T>A variant was absent from 250 controls and is reported at a frequency of 0.00035 in the East Asian population of the Exome Aggregation Consortium. The c.403+2T>A variant is observed at increased frequency in Korean ARC syndrome patients. Kim et al. (2011) demonstrated the variant results in aberrant splicing and premature truncation of the protein. Due to the potential impact of splice donor variants and the collective evidence, the c.403+2T>A variant is classified as pathogenic for arthrogryposis, renal dysfunction, and cholestasis syndrome. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.